Newspapers respond to PEPFAR reauthorization bills

NewsGuard 100/100 Score

The Seattle Post-Intelligencer and London's Guardian recently published an editorial and an opinion piece about bills (S 2731, HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief. Summaries appear below.

Editorial

Seattle Post-Intelligencer: PEPFAR requires an "early, decisive extension by Congress" because that would "send a strong signal to world leaders to join more decisively in their own efforts," a Post-Intelligencer editorial says. It adds that although the House passed its version of the reauthorization bill earlier this month, the Senate version has "encountered an unfortunate delay threat from" Sen. Tom Coburn (R-Okla.). With the Group of Eight industrialized nations summit "in Japan planned for July, it's important for the Senate to move quickly to avoid any kind of protracted delay from" Coburn for "exploiting Senate rules," the editorial says (Seattle Post-Intelligencer, 4/27).

Opinion Piece

Nina O'Farrell, Guardian: Although PEPFAR has achieved some "laudable" gains, the "effectiveness" of the program's funding is "undermined by clauses that are based on American conservative moral considerations rather than hard facts about how to prevent" HIV, O'Farrell, HIV/AIDS policy adviser for VSO, writes in an opinion piece in London's Guardian. "Despite consistent evidence that abstinence and faithfulness programs alone are not effective," the PEPFAR reauthorization bills still support such programs, O'Farrell writes, adding that the bills would require reports to Congress if abstinence and fidelity programs compose less than half of country-level spending on programs aimed at preventing sexual transmission of the virus. She concludes that President Bush "might yet be able to legitimately claim that PEPFAR is the 'most successful foreign aid program since the Marshall plan,' but only if" the "illogical restrictions upon it" are removed (O'Farrell, Guardian, 4/16).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop precise drugs to target HIV's Nef protein